{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:24:53Z","timestamp":1790061893572,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.toxicon.2012.05.003","type":"journal-article","created":{"date-parts":[[2012,5,21]],"date-time":"2012-05-21T23:22:57Z","timestamp":1337642577000},"page":"341-347","source":"Crossref","is-referenced-by-count":8,"title":["Mouse compound muscle action potential assay: An alternative method to conduct the LD50 botulinum toxin type A potency test"],"prefix":"10.1016","volume":"60","author":[{"given":"Soo-Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Beom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi-Hyeok","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hoon","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.toxicon.2012.05.003_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/026119291003800401","article-title":"The current scientific and legal status of alternative methods to the LD50 test for botulinum neurotoxin potency testing. The report and recommendations of a ZEBET meeting","volume":"38","author":"Alder","year":"2010","journal-title":"Altern. Lab. Anim"},{"issue":"12","key":"10.1016\/j.toxicon.2012.05.003_bib2","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0041-0101(01)00101-5","article-title":"A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice","volume":"39","author":"Aoki","year":"2001","journal-title":"Toxicon"},{"issue":"7","key":"10.1016\/j.toxicon.2012.05.003_bib3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0041-0101(02)00086-7","article-title":"Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety","volume":"40","author":"Aoki","year":"2002","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.toxicon.2012.05.003_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1017\/S0012162200000220","article-title":"Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial","volume":"42","author":"Barwood","year":"2000","journal-title":"Dev. Med. Child. Neurol."},{"issue":"Pt 10","key":"10.1016\/j.toxicon.2012.05.003_bib5","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1099\/00221287-143-10-3337","article-title":"Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in\u00a0vitro","volume":"143","author":"Ekong","year":"1997","journal-title":"Microbiology"},{"issue":"4","key":"10.1016\/j.toxicon.2012.05.003_bib6","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1365-2672.2009.04325.x","article-title":"An assay for botulinum toxin types A, B and F that requires both functional binding and catalytic activities within the neurotoxin","volume":"107","author":"Evans","year":"2009","journal-title":"J. Appl. Microbiol."},{"issue":"5","key":"10.1016\/j.toxicon.2012.05.003_bib7","first-page":"645","article-title":"Treatment of depression with botulinum toxin A: a case series","volume":"32","author":"Finzi","year":"2006","journal-title":"Dermatol. Surg"},{"issue":"8","key":"10.1016\/j.toxicon.2012.05.003_bib8","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/JCM.34.8.1934-1938.1996","article-title":"Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities","volume":"34","author":"Hallis","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.toxicon.2012.05.003_bib9","series-title":"Validation of Analytical Procedures: Text and Methodology, Q2 (R1), ICH Harmonised Tripartite Guideline","author":"ICH","year":"2005"},{"issue":"7","key":"10.1016\/j.toxicon.2012.05.003_bib10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","article-title":"Botulinum toxin in clinical practice","volume":"75","author":"Jankovic","year":"2004","journal-title":"J. Neural Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.toxicon.2012.05.003_bib11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/archneur.56.8.914","article-title":"Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system","volume":"56","author":"Naumann","year":"1999","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.toxicon.2012.05.003_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.toxicon.2008.06.021","article-title":"The in\u00a0vivo rat muscle force model is a reliable and clinically relevant test of consistency among botulinum toxin preparations","volume":"52","author":"Pickett","year":"2008","journal-title":"Toxicon"},{"issue":"5","key":"10.1016\/j.toxicon.2012.05.003_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.toxicon.2009.01.019","article-title":"Measurement of botulinum types A, B and E neurotoxicity using the phrenic nerve-hemidiaphragm: improved precision with in-bred mice","volume":"53","author":"Rasetti-Escargueil","year":"2009","journal-title":"Toxicon"},{"issue":"6","key":"10.1016\/j.toxicon.2012.05.003_bib14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.toxicon.2009.06.020","article-title":"Quantitative deternination of the biological activity of botulinum toxin type A by measuring the compound muscle action potential (CMAP) in rats","volume":"54","author":"Sakamoto","year":"2009","journal-title":"Toxicon"},{"issue":"5","key":"10.1016\/j.toxicon.2012.05.003_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1600-0773.1996.tb01376.x","article-title":"Refinement and validation of an alternative bioassay for potency testing of therapeutic botulinum type A toxin","volume":"78","author":"Sesardic","year":"1996","journal-title":"Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.toxicon.2012.05.003_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biologicals.2003.08.001","article-title":"Role for standards in assays of botulinum toxins: international collaborative study of three preparations of botulinum type A toxin","volume":"31","author":"Sesardic","year":"2003","journal-title":"Biologicals"},{"key":"10.1016\/j.toxicon.2012.05.003_bib17","series-title":"Botulinum Toxin: Applying the 3Rs to Product Potency Testing. NC3Rs","author":"Sesardic","year":"2009"},{"key":"10.1016\/j.toxicon.2012.05.003_bib18","series-title":"The 7th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, Oct 2\u20135, 2011, Santa Fe, NM, USA","article-title":"Reducing animal consumption for the production of botulinum neurotoxin drugs. Abstract 33, p. 51","author":"Sesardic","year":"2011"},{"issue":"6","key":"10.1016\/j.toxicon.2012.05.003_bib19","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1097\/00002508-200211001-00006","article-title":"Botulinum toxin in pain management of soft tissue syndromes","volume":"18","author":"Smith","year":"2002","journal-title":"Clin. J. Pain"},{"issue":"3","key":"10.1016\/j.toxicon.2012.05.003_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/026119290603400314","article-title":"Progress in applying the three Rs to the potency testing of botulinum toxin type A","volume":"34","author":"Straughan","year":"2006","journal-title":"Altern. Lab. Anim."},{"issue":"3","key":"10.1016\/j.toxicon.2012.05.003_bib21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0041-0101(99)00168-3","article-title":"Development of sensitive colorimetric capture elisas for Clostridium botulinum neurotoxin serotypes A and B","volume":"38","author":"Szilagyi","year":"2000","journal-title":"Toxicon"},{"issue":"2\u20133","key":"10.1016\/j.toxicon.2012.05.003_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.toxicon.2009.09.005","article-title":"Quantitative determination of biological activity of botulinum toxins utilizing compound muscle action potentials (CMAP), and comparison of neuromuscular transmission blockage and muscle flaccidity among toxins","volume":"55","author":"Torii","year":"2010","journal-title":"Toxicon"},{"issue":"9","key":"10.1016\/j.toxicon.2012.05.003_bib23","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1128\/AEM.65.9.3787-3792.1999","article-title":"Development of an in\u00a0vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay","volume":"65","author":"Wictome","year":"1999","journal-title":"Appl. Environ. Microbiol."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010112004771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010112004771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T23:17:07Z","timestamp":1594163827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010112004771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0041010112004771"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2012.05.003","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}